We advised Hadean Ventures as the lead investor in the financing round of Finnish health tech company Neuro Event Labs Oy.
Neuro Event Labs Oy provides an AI-powered diagnostic platform for epilepsy. The product, ‘Nelli’, enables better diagnosing and monitoring of epilepsy patients by analysing video and audio recordings from a patient’s bedside with computer vision. The platform identifies the type of the seizure and suggests personalised treatment.
Hadean Ventures is a life science fund manager with offices in Oslo and Stockholm that invests in life science companies across Europe with a particular focus on the Nordic region. The team at Hadean Ventures combines in-depth knowledge in both medicine and life sciences as well as venture capital investments.
